The expression and localization of PDGF f8 receptors and PDGF-AB/BB in human healing wounds was evaluated by immunohistochemical techniques and in situ hybridization. Expression of PDGF ft receptor protein and PDGF-AB/BB were analyzed in wound margin biopsies using the PDGFR-B2 and PDGF 007 antibodies. PDGF ft receptor expression was minor in normal skin. An increased expression of PDGF f receptor protein was prominent in vessels in the proliferating tissue zone in wounds as early as 1 d after surgery and was apparent c 4 wk after surgery. There was also a concordant increase in PDGF , receptor mRNA detected by in situ hybridization. PDGF-AB/ BB was present in healing wounds as well as in normal skin. In normal skin, expression of PDGF-AB /BB was confined to peripheral nerve fibers and to solitary cells of the epidermis and of the superficial dermis. In wounds, infiltrating mononuclear cells also stained for PDGF-AB/BB. To identify cell types expressing PDGF AB/BB and PDGF f receptors, respectively, we performed double immunofluorescence stainings.
Introduction
Trauma and damage to tissues are followed by a healing process during which connective tissue cells become activated to proliferate and produce components of the extracellular matrix. Certain characteristics of this process are quite similar to conditions in which tissue fibrosis is a consequence of chronic inflammation, such as scleroderma, Crohn's disease, and RA.
The initial signals which cause activation of connective tissue cells in these conditions are poorly understood. However, it is generally agreed that such activation is caused by an integrated signaling from inflammatory cells to connective tissue cells, a process in which growth factors play a central role (1) (2) (3) .
Clinical studies, as well as studies in experimental animal models, have shown that locally applied PDGF stimulates wound healing (4) (5) (6) (7) . Structurally PDGF is a dimer composed of two disulfide-bonded chains, denoted A and B. All three possible PDGF dimers; i.e., PDGF-AA, -AB, and -BB, have been isolated from natural sources (8) (9) (10) . While all forms of PDGF stimulate cultured cells of mesodermal origin to proliferate (8, 9, 1 1 ) and stimulate fibroblast mediated contraction of hydrated collagen gels (12) (13) (14) , only PDGF-AB/BB acts chemotactically (8, 9, 15) . Furthermore, PDGF-BB is more potent than PDGF-AA in stimulating wound healing in the rat ( 16 ) . The role of PDGF B chain in promoting growth of connective tissue is also supported by the observation that transfection of PDGF B chain to human melanoma alters the characteristics of tumor growth from a phenotype with virtually no stroma, to a phenotype with an excess of well-vascularized fibrous stroma ( 17) .
PDGF is produced by a variety of cultured cells including cells of the monocyte/macrophage lineage ( 8, 9, 1 1 ). Possible adjustment of PDGF production and function by cells of the immune system is indicated by the fact that some macrophagederived cytokines, such as TNF-a, IL-1, TGF-0, and PDGF itself, can regulate the expression of PDGF genes (8, 9) . In addition, IL-1 and TNF-a have been shown to inhibit the response to PDGF by target cells ( 14, 18) .
All forms of PDGF exert their effect after binding to two similar but distinct high affinity membrane receptors, the a and f3 receptors (8, 9, 19, 20) . The a receptor binds all three PDGF dimers, whereas the 1 receptor binds PDGF-BB and, with lower affinity, PDGF-AB (8, 9, 19, 20) . Ligand stimulation of PDGF a and 13 receptors leads to activation of signal tranduction pathways. These pathways are in part common for the two receptors, and in part unique. Thus, it has been shown that receptor-stimulated 13 receptors phosphorylate a partly different subset of intracellular proteins than the a receptor (21 ) . These findings provide a possible molecular background to the in part different cell physiological responses of PDGF-AA and PDGF-AB/BB, respectively. The expression of PDGF a and 1 receptors is also likely to be under separate control, since cells can express one or the other, or both (8, 9) .
In our earlier immunohistochemical evaluations of the PDGF 1 receptor expression in vivo, we have used two monoclonal antibodies, denoted PDGFR-B1 and PDGFR-B2, that specifically recognize the PDGF 1 receptor ( 19, 22) . Previous results indicate a low to absent expression ofPDGF 1 receptors in normal, adult connective tissues, such as human dermis, synovia, and in the tunica media of arteries (23) (24) (25) . A corre-sponding absence ofPDGF a receptor mRNA was observed by in situ hybridization (25, 26) . Wilcox et al. similarly reported on a low expression of PDGF 13 receptor mRNA in normal arteries (27) . PDGF 13 receptors are, however, present in capillary cells and neurons in the normal adult rat brain (27, 28) .
Neoexpression of PDGF a receptor protein and mRNA occurs in several inflammatory conditions (23, 24, 26, 27, 29) . It is particularly evident in vascular cells located in areas rich in HLA-DR expressing cells, T lymphocytes and macrophages (23, 24, 26) . In inflammatory synovitis PDGF 13 receptors are expressed by vascular smooth muscle cells and cells in capillary walls. In contrast, infiltrating T lymphocytes and a majority of the macrophages were found not to express PDGF 1 receptors (26) .
In rheumatoid synovium, PDGF B chain protein is present in the synovial lining cell layer and in macrophage-like cells of the sublining tissue (30) . Similarly, in scleroderma, macrophages and cells of the capillary wall express PDGF B chain ( 31 ) . In atherosclerotic plaques, PDGF-AB/BB was expressed predominantly by macrophages as revealed by immunohistochemistry based on the PDGF-AB/BB specific monoclonal antibody PDGF 007 (32, 33) . PDGF AB/BB is also present in the central nervous system (33) . PDGF B chain mRNA is present in arterial endothelial cells (27) and in unidentified cells in rheumatoid synovium (26) . PDGF A chain mRNA has been detected in intimal smooth muscle cells in fibrotic atherosclerotic plaques (27) and in neurons in the central nervous system (34) .
In the present study, we have used immunohistochemistry and in situ hybridization to evaluate the expression of PDGF ,3 receptors in biopsies taken from wound edges of surgical incisions during and after elective surgery in humans. We have also identified cell types expressing PDGF ,B receptors. To investigate the possible source of PDGF-AB/BB, (i.e., the ligands for the upregulated PDGF ,B receptors), we surveyed the presence of PDGF AB/BB in specimens from wounds using the PDGF 007 monoclonal antibody.
Methods
Biopsy material. Repeated biopsies were taken from 10 patients undergoing elective surgery (Table I ). In addition, biopsies were taken from healthy skin and intestine during elective surgery, and from the sciatic nerve during lower leg amputation due to occlusive arteriosclerosis. The tissue samples were stored in saline for > 20 min and were thereafter trimmed and frozen in isopenthane chilled by CO2 to -70°C and subsequently cryo-sectioned.
The study was approved by the Human Ethics Committee of the Uppsala University. Antibodies. The mouse monoclonal PDGFR-B2, used in this study has been described elsewhere (22) . It specifically stains PDGF ,B-receptors ( 19, 22) . The monoclonal PDGF 007, raised toward a synthetic peptide corresponding to amino acid residues 73-97 fragment of the PDGF B chain (35) was kindly donated to K. Funa by Mochida Pharmaceutical Company (Tokyo, Japan). The latter antibody specifically stains PDGF-AB or PDGF-BB (32, 33) , so that it has been concluded that positive staining represents the presence of either dimer (here denoted as PDGF-AB/BB). The mouse monoclonal antibodies E 11 and GI 1, reacting with parathyroid cells and tubular cells in the kidney (36) , were used as negative controls and were donated by Dr. C. Juhlin (Dept. of Surgery, University of Uppsala), the monoclonal anti-asmooth muscle actin came from Sigma Immunochemicals (St. Louis, MO), the monoclonal mouse antibody to human macrophages (anti-CD68, Dako-Macrophage) came from Dakopatts (Glostrup, Denmark), the monoclonal mouse antimacrophage antibody RFD7 (37) was kindly provided by Dr. Leonard Poulter (Department ofImmunology, Royal Free Hospital, London), and monoclonal antibodies Leu-4 (anti-CD3) and anti-HLA-DR came from Becton Dickinson (Mountainview, CA). The antineurofilament antibodies NN18 (monoclonal antineurofilament 160) and 2F11 came from Sigma Immunochemicals and Dakopatts, respectively. Biotinylated anti-mouse IgG, made in horse was from Vector Laboratories (Burlingame, CA), and goat anti-mouse Ig fluorescein conjugate came from Becton Dickinson. Staining of endothelial cells was performed (Ulex Europaeus Agglutinin 1 Fluorescein Conjugate; Vector Laboratories), which binds to blood group H antigen on the surface of endothelial cells (38) . Texas red avidin D came from Vector. All antibodies were diluted in PBS and used in optimal concentrations determined after serial dilution.
Immunohistochemical staining procedure. Frozen sections were fixed in acetone, and endogenous peroxidase was exhausted by H202, blocked with normal horse serum and with avidin/biotin blocking kit (Vector Laboratories), and subsequently subjected to immunohistochemical staining using avidin/biotin enhanced peroxidase staining (Vector Laboratories). Double immunofluorescence staining. Frozen sections were fixed in acetone, blocked with normal horse serum, followed by an avidin/biotin blocking kit (Vector Laboratories). Sections were then incubated with PDGFR-B2 (< 1 lsg/ml) or PDGF 007 (<1 ,ug/ml) for 45 min, washed, and further incubated with biotinylated horse anti-mouse IgG for 30 min. After washing, the sections were incubated with Texas red avidin for 30 min. The sections were subsequently incubated with the (26) .
In situ hybridization. The procedure used and the characteristics of the RNA probe for PDGF dl receptors have been detailed previously (26, 39) . The hybridization signals were detected by autoradiography as described (40) , and the tissue sections were stained with hematoxylin and eosin after development of the silver grains. Microscopic evaluation. Sections were evaluated in a conventional light microscope or in a Nikon Optiphot microscope equipped for immunofluorescence. The localization of PDGF receptors or PDGF-AB/BB positive cells in the wound was evaluated and described in relation to ad hoc identified zones of the healing wound (Fig. 1) .
Results
Temporal analysis ofthe expression ofPDGF receptors and PDGF-AB/BB in healing wounds. In biopsies taken from normal undamaged skin, only a minor expression of PDGF receptors in small subepidermal blood vessels was detected with immunohistochemical staining. This was in accordance with previously obtained results (25) . At the concentration of PDGFR-B2 IgG used (< 1 4g/ ml), the staining was discretely granular (Fig. 2 A, arrows) . The number of cells exhibiting such granular accumulations, as well as the number ofgranules per cell were low in biopsies from normal skin. In agreement with earlier findings (25) , no discernible expression ofPDGF receptor mRNA was detected in cryosections from normal skin by in situ hybridization (data not shown).
As early as 1 (Fig. 2 B, arrows) . The enhanced immunoexpression of PDGF receptors was present in all biopsies taken 1 d after surgery and onwards; the latest biopsies were taken between days 14 and 28 in the different patients (Table II) . A concordant increase in PDGF receptor mRNA was detected by in situ hybridization in healing wounds; PDGF receptor mRNA expression was observed in cells located in the proliferating granulation tissue and also in the original dermis adjacent to the wound edge (Fig. 3) .
The expression of PDGF-AB/BB was investigated using the monoclonal antibody PDGF 007 in normal and wounded skin. In contrast to the virtual absence of PDGF receptors in normal human skin, there was a distinct staining for PDGF-AB/BB at several locations. Thus, structures that by morphological criteria were identified as nerve fibers stained positively with PDGF 007 IgG (Fig. 4, A and B) . Distinct staining was also observed in isolated cells in the epidermis and in the epidermal-dermal junction (Fig. 4 C) . Apart from the staining of nerve fiber-like structures, there were no PDGF-AB / BB-positive cells in the dermis. In some sections, there was also a diffuse staining in the entire epidermis, the nature of which is unclear.
Already 1 d after wounding, cells staining for PDGF-AB/ BB appeared in the dermis close to the wound edge. In biopsies taken at later time points scattered cells, mostly located in the developing granulation tissue, expressed PDGF-AB/BB (Fig. 4 D) .
Characterization of PDGFR-13-and PDGF-AB/BB-expressing cells in healing wounds. Double immunofluorescence staining with the PDGFR-B2 and PDGF 007 monoclonal anti- (Fig. 7) . (Table III) . In normal skin, air * r _ e ceil eS CD68-positive macrophages were only localized in the epidermO -.^a.... ace-;<.<.mal-dermal border zone (Table III) (data not shown). ** .
The nature of the PDGF 007+/CD68 cells is not known.
* Z*-t; **2 t. ) ' However, the morphological characteristics of the PDGF 007+/CD68+ and PDGF 007+/CD68 cells were largely simi-* K : gg lar. They were large and either rounded or ofa stellate shape. A 4 g * 9 ' I ; . . , , t # 4 : -> f r e q u e n t observation was an apparent juxtaposition of cells F .Sz A cells were less pronounced, and where coarse irregular bundles ofcollagen were seen (Zone III), the capillary walls still stained for PDGF j3 receptors, however, seemingly with slightly less intensity. In the undamaged neighboring healthy dermis (Zone IV), the staining intensity was weaker. Staining for PDGF-AB/BB in nerves was observed in the normal tissue (Zone IV). It should be emphasized that no PDGF-AB/BB expressing nerves were detected in zones I-III (Fig. 1); i.e., in parts with newly formed tissues that are not innervated. In the wound zones II and III, however, there was an infiltration of PDGF-AB/BB cells, of which, as stated above, a considerable fraction were identified as macrophages.
Discussion
Wounding of human skin resulted in an increased immunoexpression of PDGF ( receptors, particularly in the vasculature; this neoexpression was evident already 1-2 d after surgery. Infiltrating T lymphocytes, HLA-DR expressing cells, and macrophages did not express PDGF (3 receptors. The latter cells were frequently found close to vessels harboring PDGF (3 receptor positive cells, suggesting that bone marrow-derived cells regulate the expression ofPDGF ( receptors and/or the availability of PDGF-AB/BB. The distribution of PDGF ( receptor-positive cells in wounds resembles that seen in rheumatoid synovia in support of our previous suggestion that neoexpression of PDGF (3 receptors is part of a common pathway in inflammatory conditions (24) . It should, however, be emphasized that PDGF ( receptor expression can also be induced by noninflammatory reactions; i.e., during adaption to cell culture conditions (24) or by certain tumors (41 ) .
PDGF ( receptor mRNA expression was also increased in wounds. Based on morphological criteria, PDGF 3 receptor mRNA expressing cells included cells in vessel walls, but also stromal cells located in the vicinity of vessels. When detected by immunostaining, PDGF ( receptors were most prominently expressed by vascular cells. However, it cannot be excluded that stromal cells located around vessels (e.g., perivascular fibroblasts) also expressed PDGF (3 receptors, in analogy to the observation in cultured fibroblasts (8, 9, 1 1 The capillary wall lining in normal adult arteries has previously been found not to express PDGF receptors (23, 26) . This is in agreement with the finding that cultured aortic endothelial cells lack PDGF receptors (8, 9, 11, 24) . However, capillary endothelial cells express PDGF receptors both in vitro and in vivo (41) (42) (43) . In the present report, we demonstrate that PDGF (3 receptors are present in the lining of capillary walls, similar to capillaries in rheumatoid synovia (26) . With the present methodology, it was not possible to conclude which cell type that expressed PDGF (3 ings indicated that endothelial cells express PDGF 13 receptors, it is also possible that all or some of the capillary cells expressing PDGF 13 receptors were pericytes. Pericytes have earlier been reported to be absent from microvessels participating in angiogenesis (44) , but a recent report has indicated their presence in newly formed capillaries in healing wounds (45). Regardless of what cell type(s) was/were responsible for the increased expression of PDGF 1 receptors in wound capillaries, our results suggest that PDGF plays a role in one or more steps in angiogenesis.
Granular accumulations of PDGF 1 receptors are characteristic of ligand-activated cultured fibroblasts, and it has been suggested that this represents internalized receptor-ligand complexes ( 14, 46 In a recent study, Antoniades et al. (47) reported on the expression of PDGF/PDGF receptors in healing partial thickness skin wounds in pigs, a wound that mainly heals by reepithelialization. The authors observed a reversible expression of both c-sis/PDGF-B mRNA and PDGF-R mRNA, and oftheir corresponding proteins in both epithelial cells and in superficial dermal fibroblasts. We occasionally observed a positive staining with the PDGF 007 IgG and PDGFR-B2 IgG. This epithelial staining appeared haphazardly in our hands, however, and as this was occasionally observed also when sections were stained with various control antibodies, the specificity of this staining, with respect to the epithelium, could not be confirmed.
In the epidermal-dermal junction area, PDGF-AB/BBexpressing cells were present in specimens from both normal and wounded skin. Many of these cells also expressed HLA-DR, similarly to the PDGF-AB/BB-expressing cells located within the epidermis, cells that tentatively were identified as Langerhans cells. The exact nature of HLA-DR and PDGF-AB/BB-expressing cells in the epidermal-dermal junction area is not known. However, class II transplantation antigenexpressing cells, so-called "dendritic macrophages" are found in close association with dermal microvessels, especially in the superficial vascular plexus, of normal human skin (48). The function of PDGF-AB/BB-expressing cells at this anatomic site is not known; PDGF 13 receptors are also expressed at this location (49) , albeit to a low degree. It is tempting to speculate that PDGF may participate in migration of dendritic cells in normal skin. Indeed, it was recently demonstrated that Langerhans cells migrate from epidermis into dermis before leaving the skin (50) .
The dermis ofthe wounds were infiltrated with PDGF-AB/ BB-positive CD68 macrophages as opposed to normal skin, where dermal infiltrates were absent or very low in number.
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Figure 7 . Double immunofluorescence staining (patient 4, day 3) showing neurofilament staining using the NN 18 antibody (A) to be strongly colocalized to staining for PDGF-AB/BB (B). 
